UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PRESERVATION OF OVARIAN FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY.

被引：0
|
作者：
Vitez, Sally F. [1 ]
Chen, Ling [1 ]
Brady, Paula C. [1 ]
Wright, Jason D. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
FERTILITY AND STERILITY | 2019年 / 112卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2019.07.412
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-9
引用
收藏
页码：E112 / E112
页数：1
相关论文
共 50 条
  • [1] Gonadotropin-Releasing Hormone Agonists for the Preservation of Ovarian Function During Chemotherapy
    Tomao, Federica
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3311
  • [2] Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer
    Lambertini, Matteo
    Falcone, Tommaso
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Del Mastro, Lucia
    Moore, Halle C. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 804 - 805
  • [3] Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer Reply
    Oktay, Kutluk
    Turan, Volkan
    Bedoschi, Giuliano
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 807 - +
  • [4] Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons
    Dolmans, Marie-Madeleine
    Taylor, Hugh S.
    Rodriguez-Wallberg, Kenny A.
    Blumenfeld, Zeev
    Lambertini, Matteo
    von Wolff, Michael
    Donnez, Jacques
    FERTILITY AND STERILITY, 2020, 114 (04) : 725 - 738
  • [5] Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
    Abdel-Razeq, Hikmat
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4273 - 4282
  • [6] Gonadotropin-Releasing Hormone Agonist for Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
    Blumenfeld, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3310
  • [7] Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
    Lambertini, Matteo
    Richard, Francois
    Nguyen, Bastien
    Viglietti, Giulia
    Villarreal-Garza, Cynthia
    CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
  • [8] The use of gonadotropin-releasing hormone analog in preservation of ovarian function in women undergoing chemotherapy. A systematic review and meta-analysis.
    Bedaiwy, M. A.
    El-Nashar, S. A.
    Desai, N.
    Hafez, F. F. Abdel
    Abdelkader, A. M.
    Falcone, T.
    FERTILITY AND STERILITY, 2007, 88 : S341 - S341
  • [9] Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists
    Hickman, Lisa C.
    Valentine, Lindsey N.
    Falcone, Tommaso
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (04) : 415 - 422
  • [10] Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer A Systematic Review and Meta-analysis
    Munhoz, Rodrigo R.
    Pereira, Allan A. L.
    Sasse, Andre D.
    Hoff, Paulo M.
    Traina, Tiffany A.
    Hudis, Clifford A.
    Marques, Ricardo J.
    JAMA ONCOLOGY, 2016, 2 (01) : 65 - 73
12345